Back to search

Article

Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer Disease

2024-06-21

Abstract excerpt

Alzheimer’s Disease (AD) is characterized by its complex and heterogeneous etiology and gradual progression, leading to high drug failure rates in late-stage clinical trials. In order to better stratify individuals at risk for AD and discern potential therapeutic targets we employed a novel procedure utilizing cell-based co-regulated gene networks and polygenic risk scores (cbPRSs). After defining genetic subtypes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89dd1967-195a-5509-806d-8fb3f2e146a1
DOI
10.1101/2024.06.21.24309255
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer DiseaseDOI 10.1101/2024.06.21.24309255
Select a neighboring publication to make it the new centre.